StockData
ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31

Addex Therapeutics Ltd.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 15, 2026
$2.89+0.13 (+4.71%)

Close on Oct 19, 2026

Addex Therapeutics Ltd. revenue by segment

No segment breakdown reported

Addex Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.